NasdaqGS:RXRXBiotechs
Is Recursion Pharmaceuticals (RXRX) Pricing Reflect Its Steep Share Price Declines And DCF Outlook
If you are wondering whether Recursion Pharmaceuticals' current share price lines up with its underlying worth, you are not alone. This article will walk through what the numbers suggest about value.
The stock last closed at US$3.98, after share price returns of a 5.0% decline over 7 days, 14.6% decline over 30 days, 5.2% decline year to date, and 46.9% decline over the past year, with a 51.4% decline over three years.
Recently, headlines around Recursion Pharmaceuticals have focused on its...